要塞 发表于 2025-3-26 21:37:33

http://reply.papertrans.cn/19/1879/187864/187864_31.png

PHON 发表于 2025-3-27 03:39:46

http://reply.papertrans.cn/19/1879/187864/187864_32.png

sorbitol 发表于 2025-3-27 08:11:10

Verallgemeinertes Berliner Verfahren (VBV)ues after TUR further treatment is necessary which is usually in the form of intravesical chemotherapy or immunotherapy. But these therapies have some disadvantages such as disturbancy to patients, adjustment of the suitable dosage, loss of active agents without using. In this study, an alternative

事情 发表于 2025-3-27 12:48:59

Verallgemeinertes Berliner Verfahren (VBV)rovide stability to the motion segment and containment for the bone graft, thereby encouraging fusion and positive remodeling. Although the use of LIFCs has been increasing due to their short term success., there are some concerns about long-term performance.. Two major variables studied for improvi

额外的事 发表于 2025-3-27 14:54:00

http://reply.papertrans.cn/19/1879/187864/187864_35.png

痛苦一生 发表于 2025-3-27 18:27:40

Microarchitectural Characterization of the Aortic Heart Valvescular disease annually.. Aortic heart valve disease, which can lead to heart failure, constitutes a high percentage of these deaths and every year approximately 60,000 aortic heart valve replacements are implanted in the US and 170,000 worldwide..

cleaver 发表于 2025-3-27 22:33:40

http://reply.papertrans.cn/19/1879/187864/187864_37.png

自恋 发表于 2025-3-28 04:32:43

Nesrin Hasirci,Vasif HasirciCovers molecular approaches as well as molecules functional in preparing and modifying biomaterials, medical devices and systems, tissue engineering and artificial organs

草率男 发表于 2025-3-28 09:01:43

http://reply.papertrans.cn/19/1879/187864/187864_39.png

金桌活画面 发表于 2025-3-28 13:23:51

https://doi.org/10.1007/978-0-306-48584-8Biochip; Biomaterial; Biomedical Informatics; Biomedical application; Tissue Engineering; biomedical appl
页: 1 2 3 [4] 5 6 7
查看完整版本: Titlebook: Biomaterials; From Molecules to En Nesrin Hasirci,Vasif Hasirci Conference proceedings 2004 The Editor(s) (if applicable) and The Author(s)